No earnings within 2 weeks of this transaction.
| Insider | Xu Cong Claire |
|---|---|
| Title | SVP, Clinical Development |
| Transaction Date | May 30, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Restricted Share Units |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jun 2, 2026 |
| Shares Purchased | 4,079 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 32,637 |
| Derivative | Derivative |
| Accession Number | 0002114309-26-000003 |
| Document | View SEC Filing |